Amendments to Regulation (EC) No 273/2004
Article 1
Annex I to Regulation (EC) No 273/2004 is amended in accordance with Annex I to this Regulation.
Commission Delegated Regulation (EU) 2025/1475 of 21 May 2025 amending Regulation (EC) No 273/2004 of the European Parliament and of the Council and Council Regulation (EC) No 111/2005 as regards the inclusion of the drug precursors 4-piperidone and 1-boc-4-piperidone in the list of scheduled substances
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
Amendments to Regulation (EC) No 273/2004
Annex I to Regulation (EC) No 273/2004 is amended in accordance with Annex I to this Regulation.
Amendments to Regulation (EC) No 111/2005
The Annex to Regulation (EC) No 111/2005 is amended in accordance with Annex II to this Regulation.
Entry into force
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .
ANNEX I In Annex I to Regulation (EC) No 273/2004, in the table for Category 1, the following entries are inserted in the list of substances in the appropriate place sequentially according to the CN Code: Substance CN designation (if different) CN Code CAS No ‘4-piperidone Piperidin-4-one 2933 39 99 41661-47-6’ ‘1-boc-4-piperidone tert-butyl 4-oxopiperidine-1-carboxylate 2933 39 99 79099-07-3.’
ANNEX II In the Annex to Regulation (EC) No 111/2005, in the table for Category 1, the following entries are inserted in the list of substances in the appropriate place sequentially according to the CN Code: Substance CN designation (if different) CN Code CAS No ‘4-piperidone Piperidin-4-one 2933 39 99 41661-47-6’ ‘1-boc-4-piperidone tert-butyl 4-oxopiperidine-1-carboxylate 2933 39 99 79099-07-3’
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.